Cargando…
Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques
Coronavirus disease 2019 (COVID-19) is an acute and highly pathogenic infectious disease in humans caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Six months after immunization with the SARS-CoV-2 vaccine, however, antibodies are almost depleted. Intradermal immunization coul...
Autores principales: | Yang, Jinling, Huo, Xinqian, Jiang, Qinfang, Liao, Yun, Zhang, Caixing, Yu, Li, Wang, Qiyan, Niu, Tingting, Li, Cong, Pi, Na, Li, Yun, Zhao, Heng, Zhang, Ying, Tan, Ying, Liao, Wenping, Li, Yong, Fan, Shengtao, Li, Qihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027951/ https://www.ncbi.nlm.nih.gov/pubmed/37003910 http://dx.doi.org/10.1016/j.vaccine.2023.03.033 |
Ejemplares similares
-
Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023) -
SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats
por: Huang, Zhangqiong, et al.
Publicado: (2021) -
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021) -
Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen
por: Fan, Shengtao, et al.
Publicado: (2019) -
Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants
por: Fan, Shengtao, et al.
Publicado: (2022)